25 years of CDMO services at the highest level

Richter-Helm BioLogics proudly celebrated the 25th company anniversary on August 22nd with the handover of the certificate by the Chamber of Commerce and Industry (IHK), Kiel.

For 25 years we have been standing for first-in-class quality, GMP-compliant biopharmaceutical CDMO services in microbial systems. For 25 years we have been supporting customers with innovation and successful project implementation leading to high customer satisfaction. We offer our customers flexible and tailor-made solutions in the areas of process development, manufacturing and analytical services, thus ensuring reliable global market supply for registered biopharmaceuticals as well as active pharmaceutical ingredients used in clinical phases.

Handover of certificate for the 25th company anniversary.

Mr Kirschberger, representative of the Chamber of Commerce in Kiel, and Dr. Pohlmeyer, Managing Director at Richter-Helm BioLogics

This might interest you

Biotechnologische Produktion ist unsere DNA

CORONA WAR EIN BOOSTER FÜR DIE BIOTECHNOLOGIE-BRANCHE.
Die Richter-Helm Biologics GmbH & Co. KG aus Hamburg ist seit über 30 Jahren ein Lohnhersteller für biopharmazeutische Produkte. Mit großer Expertise im Bereich der DNA-Impfstoffe war das Unternehmen während der Pandemie für große US Entwicklungsunternehmen ein wichtiger Produktionspartner.
Mit neuen Produktionsanlagen will das Unternehmen jetzt seine Kapazitäten für die kommenden Jahre weiter ausbauen.

read more

A guide to the analysis of plasmid DNA

Plasmids are circular, double-stranded DNA molecules of various sizes originally found in bacteria, archaea and eukaryotic yeast. They replicate independently of chromosomal DNA and are easily genetically modified. Plasmids can be used for a variety of pharmaceutical purposes: as the active pharmaceutical ingredient (API) in DNA vaccines to prevent viral infections or cancer development; as critical raw material, starting material or ancillary material for viral vector production; or as template for mRNA-based products.

read more

Delivering flexible and transparent manufacturing processes

Developing and manufacturing microbial-derived biopharmaceutical products require deep expertise and reliable solutions that can guide a project to success while meeting evolving industry standards. To this end, pharmaceutical companies need expert partners capable of bringing promising cures to the market on time, regardless of scale.

read more